Location History:
- Rancho Santa Fe, CA (US) (1993 - 1998)
- Escondido, CA (US) (1995 - 1999)
Company Filing History:
Years Active: 1993-1999
Title: The Innovative Contributions of Eva Engvall
Introduction
Eva Engvall is a prominent inventor based in Rancho Santa Fe, California. She has made significant contributions to the field of molecular biology, particularly through her work on merosin, a protein that plays a crucial role in nerve growth and development. With a total of six patents to her name, Engvall's innovations have the potential to impact both therapeutic and diagnostic applications.
Latest Patents
Engvall's latest patents include groundbreaking inventions related to nucleic acids encoding merosin. One of her notable inventions provides an isolated nucleic acid molecule that encodes a subunit of the protein merosin, which has an apparent molecular weight of about 800 kD. This invention also includes isolated nucleic acid molecules that encode merosin fragments, as well as anti-merosin antibodies and vectors for the recombinant production of merosin. Furthermore, her work highlights the use of merosin to promote neurite growth and its applications in diagnostics.
Career Highlights
Throughout her career, Eva Engvall has worked with esteemed organizations such as the La Jolla Cancer Research Foundation and Washington University. Her research has been instrumental in advancing our understanding of merosin and its implications in medical science. Engvall's dedication to her work has established her as a leading figure in her field.
Collaborations
Engvall has collaborated with notable colleagues, including Ilmo Leivo and Joshua R Sanes. These partnerships have further enriched her research and contributed to the development of her innovative patents.
Conclusion
Eva Engvall's contributions to the field of molecular biology through her patents on merosin exemplify her commitment to innovation and research. Her work not only enhances our understanding of important biological processes but also opens new avenues for therapeutic and diagnostic advancements.